cfDNA Extraction from Plasma (Round 2)
EQA for quality and quantity of cfDNA extracted from plasma. There are two rounds of EQA per year which need to be purchased separately. This EQA will be distributed in Sept 2027. This EQA is sponsored.
Overview
The scheme is designed to assess the pre-analytical process for extraction of cfDNA.
Participants will receive an individual report including educational advice and a scheme summary report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics which allow participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
At a glance
Product Code:
06-CFDNA-RD2-27
Target/Genes:
Quality and quantity of cfDNA extracted from plasma
Technology:
DNA extraction
Sample Type:
Plasma (cfDNA)
Submit Results In:
English
Accredited:
No
Key Dates
28/02/2027
Sep-27
September - October 2027
February 2028
Sample Details
Three artificial plasma samples (4ml) designed to mimic patient samples will be provided for cfDNA extraction.
EQA Results
Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
Participation Information
Participants are expected to extract cfDNA from the samples according to their routine strategy. Participants are responsible for returning the extracted cfDNA in tubes and packaging provided by EMQN and must complete the data collection form.
This EQA is supported by an educational grant from AstraZeneca, fees are subsidised so there is a no cost for participants. EMQN would like to acknowledge and thank AstraZeneca for this support.
Participation is limited, please register early to avoid disappointment. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc).
Send your enquiry by submitting the form
Closes in 111 days
Free
Buying is completed on the EMQN portal and needs a free EMQN account, which takes a few minutes to set up.
- Submit results in 1 language
Questions about this scheme?
Contact our team
Register Interest
Express your interest in ''.